Morphea - 硬斑病https://en.wikipedia.org/wiki/Morphea
硬斑病 (Morphea) 是硬皮症的一種,可使臉部、手部、腳部或身體其他部位的皮膚變硬,但不涉及內臟器官。硬斑症是由於膠原蛋白過度沉積而導致的皮膚和皮下組織增厚和硬化。硬斑病與「系統性硬化症」的差別在於不涉及內臟。

硬斑病是一種非常罕見的疾病。由於照片的構圖,演算法可能會將其誤認為 硬斑病 (morphea) 。

☆ 德國 Stiftung Warentest 2022 年的結果顯示,消費者對 ModelDerm 的滿意度僅略低於付費遠距醫療諮詢。
  • 硬斑病 (Morphea) 的病灶通常表現為萎縮性色素斑塊。
  • Frontal linear scleroderma
  • Frontal linear scleroderma
  • 變薄(或褪色)的黑白病變可疑硬斑病 (Morphea)。
References Localized scleroderma: clinical spectrum and therapeutic update 25672301 
NIH
Scleroderma 是一種影響結締組織的罕見疾病,表現為皮膚硬化,有時會影響身體的其他部位。主要有兩種類型: systemic sclerosis ,涉及皮膚硬化和內臟器官; localized scleroderma ,也稱為硬斑病,通常僅限於皮膚及其下面的組織,具有良性和自限性病程。儘管局限性硬皮症並不常見,其病因尚不清楚,但最近的研究表明,它也會影響內臟並導致各種健康問題。鑑於 localized scleroderma 潛在的嚴重性,早期治療對於預防併發症至關重要。
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
 Upcoming treatments for morphea 34272836 
NIH
Morphea ,也稱為局部硬皮病,是一種影響結締組織的罕見自體免疫疾病。它可以以不同的方式出現,而且並不常見,每年每 10 萬人中大約有 0. 4 - 2. 7 例。 Morphea 常見於 2 至 14 歲的兒童,且女孩比男孩更容易受到影響。
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.